Mabylon AG, a leader in the high-throughput discovery, characterization, and development of human-derived antibodies, today announced that it has received three grants totaling more than CHF 1.3 ...

To be able to manage important aspects of my environment and control access to entertainment gives me back the independence ...

Amyotrophic lateral sclerosis (ALS), also known as Lou Gehrig's disease, is the most common degenerative motor neuron disease ...

A short course of treatment with RNS60, as an add-on to riluzole, extended the survival of ALS patients by about six months, ...

The Japan Early-stage Trial of Ultrahigh-Dose Methylcobalamin for ALS (JETALS) is an investigator-initiated study conducted as a multicenter, placebo-controlled, double-blind, randomized Phase III ...

The following is a summary of “How to detect affect recognition alterations in amyotrophic lateral sclerosis,” published in the September 2024 issue of Neurology by Castelnovo et al. Researchers condu ...

Athira Pharma has been on a bumpy road in recent years, and, now, the company is restructuring and shedding weight to try to keep the journey going.  | Just a couple of weeks after announcing that its ...

A blood test has been shown to accurately identify patients with amyotrophic lateral sclerosis at early stages, which could ...

A highly accurate diagnostic blood test has been developed for amyotrophic lateral sclerosis (ALS), a progressive ...

Prince William and Kate Middleton have offered their support to Lindsey Burrow, the widow of late British rugby star Rob ...

Motor neuron diseases are a group of progressive and ultimately fatal neurodegenerative disorders of the motor system, ...

TOKYO, Sept 24, 2024 - (JCN Newswire) - Eisai Co., Ltd. announced today that it has obtained manufacturing and marketing authorization approval for amyotrophic lateral sclerosis (ALS) treatment ...